Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) EBT (2016 - 2025)

Historic EBT for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $340000.0.

  • Nephros' EBT rose 8579.23% to $340000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 26913.72%. This contributed to the annual value of $89000.0 for FY2024, which is 10565.08% up from last year.
  • According to the latest figures from Q3 2025, Nephros' EBT is $340000.0, which was up 8579.23% from $246000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' EBT ranged from a high of $579000.0 in Q1 2025 and a low of -$1.6 million during Q1 2022
  • For the 5-year period, Nephros' EBT averaged around -$437684.2, with its median value being -$422000.0 (2023).
  • Its EBT has fluctuated over the past 5 years, first tumbled by 5814.81% in 2022, then skyrocketed by 42897.73% in 2025.
  • Nephros' EBT (Quarter) stood at -$726000.0 in 2021, then increased by 5.1% to -$689000.0 in 2022, then increased by 9.72% to -$622000.0 in 2023, then skyrocketed by 158.52% to $364000.0 in 2024, then decreased by 6.59% to $340000.0 in 2025.
  • Its EBT stands at $340000.0 for Q3 2025, versus $246000.0 for Q2 2025 and $579000.0 for Q1 2025.